![Adam Widman (@adamjwidman) 's Twitter Profile](https://pbs.twimg.com/profile_images/1483078801160650752/1ke2mp0T_200x200.jpg)
Adam Widman
@adamjwidman
Breast medical oncology @sloan_kettering, liquid biopsy @landau_lab. AI and cancer genomics
ID: 1483078029064736770
17-01-2022 14:05:40
47 Tweet
207 Followers
50 Following
![Nir Ben Chetrit (@chetritnir) 's Twitter Profile Photo Nir Ben Chetrit (@chetritnir) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1615866497452097536/Z2p8q_f0_200x200.jpg)
Very excited to share our latest work from the Dan Landau, where we uncover the spatial determinants underlying macrophage heterogeneity and self-renewal in breast cancer. biorxiv.org/content/10.110…
![Adam Widman (@adamjwidman) 's Twitter Profile Photo Adam Widman (@adamjwidman) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1483078801160650752/1ke2mp0T_200x200.jpg)
![Weill Cornell Medicine (@weillcornell) 's Twitter Profile Photo Weill Cornell Medicine (@weillcornell) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1679104004255625217/-ZcRNtWt_200x200.jpg)
An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, says a team led by Dr. Dan Landau (Dan Landau) and researchers at NY Genome Center and Memorial Sloan Kettering Cancer Center. bit.ly/45pXCJ3
![Weill Cornell Medicine (@weillcornell) on Twitter photo An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, says a team led by Dr. Dan Landau (<a href="/landau_lab/">Dan Landau</a>) and researchers at <a href="/nygenome/">NY Genome Center</a> and <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>.
bit.ly/45pXCJ3 An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, says a team led by Dr. Dan Landau (<a href="/landau_lab/">Dan Landau</a>) and researchers at <a href="/nygenome/">NY Genome Center</a> and <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>.
bit.ly/45pXCJ3](https://pbs.twimg.com/media/GQCTPOfWwAAKM6J.jpg)
![Eric Topol (@erictopol) 's Twitter Profile Photo Eric Topol (@erictopol) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1589325138960318464/2OwvQAWC_200x200.jpg)
A major problem with cell-free tumor DNA to detect cancer (Liquid biopsy) is its very low quantity. Today Nature Medicine use of #AI to overcome that issue with impressive results for radical signal-to-noise enrichment nature.com/articles/s4159… free access rdcu.be/dKNOx
![Eric Topol (@erictopol) on Twitter photo A major problem with cell-free tumor DNA to detect cancer (Liquid biopsy) is its very low quantity. Today <a href="/NatureMedicine/">Nature Medicine</a> use of #AI to overcome that issue with impressive results for radical signal-to-noise enrichment
nature.com/articles/s4159…
free access rdcu.be/dKNOx A major problem with cell-free tumor DNA to detect cancer (Liquid biopsy) is its very low quantity. Today <a href="/NatureMedicine/">Nature Medicine</a> use of #AI to overcome that issue with impressive results for radical signal-to-noise enrichment
nature.com/articles/s4159…
free access rdcu.be/dKNOx](https://pbs.twimg.com/media/GQChAVQaQAEtphx.jpg)
![Marcin Imieliński (@skimomiks) 's Twitter Profile Photo Marcin Imieliński (@skimomiks) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1586411430894571521/n17_iDzy_200x200.jpg)
parts per million -> parts per billion -> parts per trillion? how low can we go with ctDNA detection in the era of dirt cheap whole genomes ?? .. momentous milestone by Adam Widman Dan Landau & team👇👇👇
![Pashtoon Kasi MD, MS (@pashtoonkasi) 's Twitter Profile Photo Pashtoon Kasi MD, MS (@pashtoonkasi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1457312777308098560/UALRqbF3_200x200.jpg)
#NESTTrial 🪺 responses to date.🙌🏾 What’s particularly of note is the deepening of the responses with longer time to brew 🫖. The pattern🌊 and lack of recurrence speaks to curative potential of immunotherapy for both MSS and MSI-High tumors. #CRCSM ESMO - Eur. Oncology #ESMOGI24 OncoAlert
![Pashtoon Kasi MD, MS (@pashtoonkasi) on Twitter photo #NESTTrial 🪺 responses to date.🙌🏾
What’s particularly of note is the deepening of the responses with longer time to brew 🫖. The pattern🌊 and lack of recurrence speaks to curative potential of immunotherapy for both MSS and MSI-High tumors. #CRCSM
<a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI24 <a href="/OncoAlert/">OncoAlert</a> #NESTTrial 🪺 responses to date.🙌🏾
What’s particularly of note is the deepening of the responses with longer time to brew 🫖. The pattern🌊 and lack of recurrence speaks to curative potential of immunotherapy for both MSS and MSI-High tumors. #CRCSM
<a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI24 <a href="/OncoAlert/">OncoAlert</a>](https://pbs.twimg.com/media/GRLNApbX0AAZ2GB.jpg)